Fortress Biotech, Inc. (FBIOP) Gross Profit (2015 - 2026)

Fortress Biotech's Gross Profit history runs 11 years deep, the most recent figure standing at $8.6 million for Q4 2025.

• In Q4 2025, Gross Profit fell 17.79% year-over-year to $8.6 million; the TTM figure through Dec 2025 stood at $38.9 million (up 5.63% YoY), while the FY2025 annual figure was $40.3 million, up 9.56% from the prior year.
• Gross Profit for Q4 2025 stood at $8.6 million, down from $11.9 million in the prior quarter.
• The five-year high for Gross Profit was $49.0 million in Q4 2021, with the low at -$65.2 million in Q4 2022.
• The 5-year median for Gross Profit is $8.4 million (2021), against an average of $2.9 million.
• The sharpest annual moves came in 2021 and 2022: Gross Profit jumped 418.57% in 2021, then plunged 233.11% in 2022.
• Fortress Biotech's Gross Profit stood at $49.0 million in 2021, then slumped by 233.11% to -$65.2 million in 2022, then jumped by 119.96% to $13.0 million in 2023, then declined by 19.43% to $10.5 million in 2024, then declined by 17.79% to $8.6 million in 2025.
• Business Quant data shows FBIOP's Gross Profit at $8.6 million in Q4 2025, $11.9 million in Q3 2025, and $10.1 million in Q2 2025.